Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-324-8 | CAS number: 70131-50-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well documented study
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicological evalution and metal bioavailibility in pregnant rats following exposure to clay minerals in the diet
- Author:
- Wiles MC, Huebner HJ, Afriyie-Gyawu E, Taylor RJ, Bratton GR & Phillips TD
- Year:
- 2 004
- Bibliographic source:
- Jounal of Toxicology and Environmental Health, Part A,67:863-874.
Materials and methods
- Principles of method if other than guideline:
- Calcium montmorillonite and sodium montmorillonite clays were supplemented in the balanced diet of rats during pregnancy at a level of 2% w/w. Evaluations of toxicity were performed on gestation d 16.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Calcium montmorillonite
- IUPAC Name:
- Calcium montmorillonite
- Reference substance name:
- Sodium montmorillonite
- IUPAC Name:
- Sodium montmorillonite
- Details on test material:
- - Name of test material (as cited in study report): Calcium montmorillonite clay (Novasil plus,NSP) Sodium montmorillonite clay (sWY-2)
- Other:NSP was obtained from Engelhard Corporation(Cleveland, OH). Wyoming sodium montmorillonite (Swy-2) was obtained from the clay minerals respository( Univeristy of Missour, Columbia).
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague-Dawley, Inc., Houston, TX
- Age at study initiation: Ten week-old
- Housing: Filter-top polycarbonate cages housed in a temperature-controlled and artificially illuminated room free from any sources of chemical contamination
- Diet : ad libitum
- Water :ad libitum
- Acclimation period:3-4 days
ENVIRONMENTAL CONDITIONS
- Photoperiod (hrs dark / hrs light):12h dark/ 12h light cycle
Administration / exposure
- Route of administration:
- other: Oral feed and by gavage
- Details on exposure:
- Three diets were prepared from a balanced powdered rodent feed and included 1) basal feed, 2) basal feed with 2% NSP (w/w) and 3) basal feed with 2% Swy-2 (w/w). To ensure a continuous presence of clay in the stomach, animals maintained on diets containing clay were gavaged once per day midway through the fasting period with the respective clay between gestation d 1 and 15. The gavage dose (0.25%) aqueous suspension) was selected as the maxmium amount of clay that could be suspended in 1ml without increasing the viscosity beyond the ability to deliver the dose through the gavage needle. Stock clay suspensions were made by shaking 25 g clay in 400 ml UP-H2O overnight.
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- no data
- Details on mating procedure:
- After an acclimation period, females were paired with males overnight.
- Duration of treatment / exposure:
- Day 1 to 15 of pregnancy
- Frequency of treatment:
- Gavaged once per day midway through the fasting period( 12 h light cycle) with the respective clay between gestation day 1 and 15
- Duration of test:
- 16 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
2% w/w (equivalent to 1000-1500 mg/kg bw/day)
Basis:
nominal in diet
- No. of animals per sex per dose:
- 6 animals per treatment group
- Control animals:
- yes, plain diet
- Details on study design:
- no data
Examinations
- Maternal examinations:
-
Maternal liver, kidneys, tiba, brain, uterus, pooled placentas, and pooled embryonic mass were collected, weighed, and frozen prior to metal analysis
BODY WEIGHT: Yes
- Time schedule for examinations:
Maternal body weight at day 1 and day 16
Litter weight
OTHER:
Total feed intake - Ovaries and uterine content:
- no data
- Fetal examinations:
- The uterine wall was cut open and the number of implants, resorptions, and dead and live fetuses were counted.
- Statistics:
- Unless otherwise noted, all values are expressed as means ± standard error of the mean. Mean values for body and organ weights, feed intake, and developmental toxicity parameters were calculated from six rats in each treatment group. From those six rats, three were randomly selected for determination of metal content via neutron activation analysis. Data were compared statistically using the Gernal Linear Model procedure with Turkey's test and were considered significant if p< 0.05.
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
no data
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 - 1 500 mg/kg bw/day (nominal)
- Basis for effect level:
- other: other:
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
no data
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Table 1: Effects of clay-based diets on implementations, resorptions, and embryos in the pregnant rat
|
Control dieta |
2% Swy-2a |
2% NSP dieta |
Implantations |
17±1 |
15±1 |
17±1 |
Embryos |
15±1 |
14±1 |
15±1 |
Resorptions |
1±1 |
1±0 |
2±1 |
Note. All data are expressed as mean values for 6 rats per treatment group ± SD. Mean values for rats maintained on Swy-2 and NSP diets were not statistically different (p≤0.05) from controls.
aClays (NSP and Swy-2) were added to a powdered basal diet at a level of 2% (w/w) and fed to the rats between day 1 and 15 of pregnancy. Test animals were dosed orally with 0.25% clay in 1 ml aqueous suspension once per day (midway through the fasting period). Animals fed the control diets were dosed orally with 1ml aqueous vehicle alone
Table 2: Effects of Clay-based diets on tissue weights in the pregnant rat
Tissuesa |
Weight of tissues from rats fed control dietb(g) |
Weight of tissues from rats fed 2% Swy-2 dietb(g) |
Weight of tissues from rats fed 2% NSP dietb(g) |
Liver |
12.6±0.7 |
12.5±0.4 |
12.7±1.0 |
Right kidney |
1.0±0.0 |
1.0±0.1 |
1.0±0.1 |
Left kidney |
1.0±0.1 |
1.0±0.0 |
1.0±0.1 |
Brain |
1.7±0.0 |
1.6±0.1 |
1.7±0.0 |
Right tibia |
0.5±0.0 |
0.5±0.1 |
0.5±0.0 |
Left tiba |
0.5±0.1 |
0.5±0.1 |
0.5±0.0 |
Uterus |
4.6±0.4 |
4.4±0.6 |
4.7±0.3 |
Pooled placentas |
5.1±0.8 |
4.8±1.1 |
5.0±0.8 |
Pooled embryonic mass |
7.3±0.7 |
6.7±1.6 |
7.2±0.9 |
Note. All data are expressed as mean values for 6 rats per treatment group ± SD. Mean weights of tissues of rats maintained on Swy-2 and NSP diets were not statistically different (p≤0.05) from controls.
aTissues were collected from pregnant rats at gestation day 16.
bClays (NSP and Swy-2) were added to a powdered basal diet at a level of 2% (w/w) and fed to the rats between day 1 and 15 of pregnancy. Test animals were dosed orally with 0.25% clay in 1 ml aqueous suspension once per day (midway through the fasting period). Animals fed the control diets were dosed orally with 1ml aqueous vehicle alone
Table 3: Effects of Clay-based diets on gain in maternal body weight, Litter weight, and feed intake in the pregnant rat
Treatmenta |
Maternal body weight at day 1 (g) |
Maternal body weight at day 16 (g) |
Gain in maternal body weight (g) |
Litter weight (g) |
Total feed intake (g) |
Control diet |
241±11.8 |
309±7.4 |
68.0±5.7 |
28.9±1.1 |
330±13 |
2% Swy-2 diet |
237±9.1 |
308±8.7 |
71.0±3.5 |
27.0±2.1 |
352±7 |
2% NSP diet |
240±7.4 |
309±8.1 |
69.3±3.5 |
29.2±1.4 |
345±7 |
Note. All data are expressed as mean values for 6 rats per treatment group ± SD. Mean values for rats maintained on Swy-2 and NSP diets were not statistically different (p≤0.05) from controls.
aClays (NSP and Swy-2) were added to a powdered basal diet at a level of 2% (w/w) and fed to the rats between day 1 and 15 of pregnancy. Test animals were dosed orally with 0.25% clay in 1 ml aqueous suspension once per day (midway through the fasting period). Animals fed the control diets were dosed orally with 1ml aqueous vehicle alone
Applicant's summary and conclusion
- Conclusions:
- 2% calcium montmorillonite or sodium montmorillonite in the diet had no effect on maternal weight or maternal organ weights, litter weight, embryonic implantations, or resorptions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.